Focus

DSIP.

Available Variants

5 mg 10 mg 15 mg

View lab reports Quality process

Research area: Focus

🛡️

For research purposes only. Not intended for use in humans or animals.

Neuroscience research

About DSIP

DSIP is studied in the context of neuroscience and cognitive research. DSIP is associated with modulation of GABA and glutamate signaling in the central nervous system, studied in connection with slow-wave (deep) sleep phases.

Research Application

Studied in sleep research in connection with slow-wave (deep) sleep phases. Despite its name, a direct sleep-inducing effect in humans is not consistently demonstrated — the evidence base remains mixed.

Important to know

Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.

Content 5 mg, 10 mg, 15 mg

Form Lyophilized powder

Category Focus

Purity & Identity see lab reports →

Sequence / Structure 9 amino acids – Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu

Regulatory Status Isolated in 1977 by Schoenenberger and Monnier from cerebral venous blood in rabbits. Not FDA approved; classified as an FDA Category 2 bulk substance since 2024.

Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.

Research Overview

Studies on neuroscience-related peptides are predominantly preclinical.

Schneider-Helmert D, Schoenenberger GA. Neuropsychobiology. 1983;9(4):197–206. PMID 6895513
Dick P, et al. Eur Neurol. 1984;23(5):364–371. PMID 6548969
Larbig W, et al. Eur Neurol. 1984;23(5):372–385. PMID 6548970

References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.

Question about DSIP?

We reply personally – via email or Telegram.

✉️ Email ✈️ Telegram

← Back to overview